These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1324672)

  • 1. Phosphorylation of the Epstein-Barr virus nuclear antigen 2.
    Grässer FA; Göttel S; Haiss P; Boldyreff B; Issinger OG; Mueller-Lantzsch N
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1694-701. PubMed ID: 1324672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
    Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
    Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.
    Szekely L; Selivanova G; Magnusson KP; Klein G; Wiman KG
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5455-9. PubMed ID: 8390666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the Epstein-Barr virus nuclear antigen 2 by far-Western blotting and DNA-binding studies.
    Sauder C; Götzinger N; Schubach WH; Horvath GC; Kremmer E; Krebs A; König S; Zimber Strobl U; Mueller Lantzsch N; Grässer FA
    J Gen Virol; 1996 May; 77 ( Pt 5)():991-6. PubMed ID: 8609497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I.
    Sabbatini A; Bombardieri S; Migliorini P
    Eur J Immunol; 1993 May; 23(5):1146-52. PubMed ID: 8386666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative sequence analyses of Epstein-Barr virus nuclear antigen-2 and -3B genes of a fresh Epstein-Barr virus-2 isolate.
    Inoue N; Kikuta H; Yanagi K
    Intervirology; 1992; 33(4):180-6. PubMed ID: 1339417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro.
    Chen MR; Chang SJ; Huang H; Chen JY
    J Virol; 2000 Apr; 74(7):3093-104. PubMed ID: 10708424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1).
    Polvino-Bodnar M; Kiso J; Schaffer PA
    Nucleic Acids Res; 1988 Apr; 16(8):3415-35. PubMed ID: 2836795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of fusion proteins of Epstein-Barr virus nuclear antigens in E. coli and their antigenicity.
    Inoue N; Harada S; Yanagi K
    J Virol Methods; 1991; 31(2-3):301-14. PubMed ID: 1713918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif.
    Schubert U; Henklein P; Boldyreff B; Wingender E; Strebel K; Porstmann T
    J Mol Biol; 1994 Feb; 236(1):16-25. PubMed ID: 8107101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The type-specific epitopes of the Epstein-Barr virus nuclear antigen 2 are near the carboxy terminus of the protein.
    Rowe DT; Clarke JR
    J Gen Virol; 1989 May; 70 ( Pt 5)():1217-29. PubMed ID: 2471806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
    Ling PD; Rawlins DR; Hayward SD
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9237-41. PubMed ID: 8415684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
    Maunders MJ; Petti L; Rowe M
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen.
    Rhodes G; Carson DA; Valbracht J; Houghten R; Vaughan JH
    J Immunol; 1985 Jan; 134(1):211-6. PubMed ID: 2981091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7.
    Hill A; Worth A; Elliott T; Rowland-Jones S; Brooks J; Rickinson A; McMichael A
    Eur J Immunol; 1995 Jan; 25(1):18-24. PubMed ID: 7531143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic peptide substrate specific for casein kinase I.
    Agostinis P; Pinna LA; Meggio F; Marin O; Goris J; Vandenheede JR; Merlevede W
    FEBS Lett; 1989 Dec; 259(1):75-8. PubMed ID: 2599114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.
    Wang Y; Finan JE; Middeldorp JM; Hayward SD
    Virology; 1997 Sep; 236(1):18-29. PubMed ID: 9299613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of phosphorylation sites in the cytoplasmic domain of the 300 kDa mannose-6-phosphate receptor.
    Rosorius O; Mieskes G; Issinger OG; Körner C; Schmidt B; von Figura K; Braulke T
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):833-8. PubMed ID: 8318012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.
    Milman G; Scott AL; Cho MS; Hartman SC; Ades DK; Hayward GS; Ki PF; August JT; Hayward SD
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6300-4. PubMed ID: 2412231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
    Sample C; Parker B
    Virology; 1994 Dec; 205(2):534-9. PubMed ID: 7975254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.